CCC getting smacked down 5% to 95c is tempting but I'm staying on the sidelines until we see if this biotec…by @k_maphosa on $CCC

CCC getting smacked down 5% to 95c is tempting but I'm staying on the sidelines until we see if this biotech name can hold above the 90c support, revenue growth looks decent on paper but execution risk is still too high for me right now.